SCHEMBL14898564

SCHEMBL14898564

CCCCCCCCCCCCC1CCCCCCCCCCCCCN1C(=O)OCC(C)C

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.50
S1PR1 P21453 2/20 0.43
S1PR3 Q99500 2/20 0.43
S1PR5 Q9H228 2/20 0.43
POLB P06746 1/20 0.43
MEN1 O00255 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39
HTT P42858 1/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNA7 P36544 1/20 0.38
CHRNA4 P43681 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14898563 1.00 RAB9A (0.50) RAB9AS1PR1S1PR3S1PR5POLB
SCHEMBL10141474 0.94 RAB9A (0.57) RAB9AS1PR1S1PR3S1PR5POLB
SCHEMBL17627000 0.87 S1PR1 (0.48) S1PR1S1PR3S1PR5MEN1TP53
SCHEMBL8800154 0.86 RAB9A (0.53) RAB9APOLBMEN1TP53KMT2A
SCHEMBL10119377 0.83 RAB9A (0.57) RAB9APOLBMEN1KMT2AHTT
SCHEMBL1146693 0.83 RAB9A (0.56) RAB9APOLBMEN1KMT2AHTT
SCHEMBL28064109 0.83 RAB9A (0.58) RAB9APOLBMEN1MAPTKMT2A
SCHEMBL10142030 0.81 S1PR1 (0.45) RAB9AS1PR1S1PR3S1PR5POLB
SCHEMBL9978245 0.80 RAB9A (0.58) RAB9APOLBMEN1KMT2AHTT
SCHEMBL4541731 0.80 RAB9A (0.58) RAB9APOLBMEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8431576-B2 Heterocyclic compounds for the treatment of neurological and psychological disorders ALKERMES PHARMA IRELAND LIMITED (IE) 2013-04-30 US disclosed